Literature DB >> 26670554

Empagliflozin/metformin (Synjardy) for type 2 diabetes.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26670554

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  2 in total

1.  Metformin monotherapy for adults with type 2 diabetes mellitus.

Authors:  Filip Gnesin; Anne Cathrine Baun Thuesen; Lise Katrine Aronsen Kähler; Sten Madsbad; Bianca Hemmingsen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-05

Review 2.  Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review.

Authors:  Rohit Kedia; Supriya Kulkarni; Meredith Ross; Vijay Shivaswamy
Journal:  Patient Prefer Adherence       Date:  2016-09-30       Impact factor: 2.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.